| Name | Title | Contact Details |
|---|---|---|
Philip Johnson |
Chief Human Resources Officer | Profile |
Exempla Saint Joseph Hospital is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Reading Hospital Medical Group is a Reading, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
A warm and genuine welcome to the website of CarePoint Health, Inc. We are a leading Healthcare company headquartered in Houston, Texas. At CarePoint Health, we have assembled a team of caring and experienced professionals who focus on providing world-class care one patient at a time. We believe in establishing enduring relationships with our family of patients, clinicians and physicians within the communities in which we operate - taking great pride in going over and above the call of duty. At CarePoint, service excellence is not a buzzword; it is a core part of our DNA. CarePoint Health as a company is focused on addressing the persistent need for a quality end-to-end provider of non-institutional healthcare services. Licensed by The Texas Department of Health and accredited by The Joint Commission (JCAHO), CarePoint Health has a committed focus on quality management programs by constantly monitoring, evaluating, and improving agency operations. We kindly encourage you and your loved ones to take a moment to learn more about who we are and what we do. We hope you and your loved ones will always enjoy the very best of health, but when you or your loved ones health needs reliable and caring service, we do genuinely hope that you will call on CarePoint Health.
Clallam County Hospital District is a Forks, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.